Cancer Gene Therapy IndustryThe global cancer gene therapy industry is projected to increase at a compound annual growth rate (CAGR) of 10.1% from 2022 to 2032, with a projected value of US$ 2 billion in 2022. According to Future Market Insights (FMI), the oncolytic virotherapy category held 49.3% of the global canc.
From 2022 to 2032, the global cancer gene therapy market is anticipated to expand at a 10.1% compound annual growth rate (CAGR) and reach US$ 2 billion in 2022. The oncolytic virotherapy segment held 49.3% of the global cancer gene therapy market in 2021, according to Future Market Insights (FMI). This market is pro.
Tentarix is developing biologic therapies that target specific cells in the body and could be used to fight cancer and autoimmune diseases while limiting side effects
Adaptimmune Announces Changes to Board of Directors streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.